Moreover, adiponectin inhibits leptin signaling by downregulating sterol regulatory element-binding protein 1 (SREBP-1) and FAS (CD95)-related enzymes to inhibit fatty acid synthesis in BC cells. Here, ADIPOQ is linked to breast cancer.